917 resultados para comets: individual: 107P (4015) Wilson-Harrington
Resumo:
Iowa School District Surtax Report 2005
Resumo:
Iowa Individual Income Tax Statistical Report 1997
Resumo:
Iowa Individual Income Tax Statistical Report 1998
Resumo:
Iowa Individual Income Tax Statistical Report 1999
Resumo:
Iowa Individual Income Tax Statistical Report 2000
Resumo:
Iowa Individual Income Tax Statistical Report 2001
Resumo:
Iowa Individual Income Tax Statistical Report 2002
Resumo:
Iowa Individual Income Tax Statistical Report 2003
Resumo:
Iowa Individual Income Tax Statistical Report 2004
Resumo:
Iowa Individual Income Tax Statistical Report 2005
Resumo:
Guide manual for using the Human Resource Information System for the state of Iowa.
Resumo:
Guide manual for using the Human Resource Information System for the state of Iowa.
Resumo:
Afídeos do gênero Cinara Curtis são importantes pragas de coníferas em vários países. No Brasil Cinara atlantica (Wilson, 1919) tem causado danos em plantações comerciais de Pinus spp. e o controle biológico com predadores pode ser uma opção melhor que o controle químico. Este trabalho teve por objetivo estudar a biologia e a capacidade de predação dos coccinelídeos Hippodamia convergens Guérin-Méneville, 1842, Cycloneda sanguinea (Linnaeus, 1763) e Eriopis connexa (German, 1824) (Coleoptera, Coccinellidae) sobre ninfas de C. atlantica. O estudo foi conduzido sob condições controladas (temperatura: 23 ± 1ºC, UR: 70 ± 10% e fotofase: 14 h.). Foi verificado que ninfas de C. atlantica são adequadas como alimento para as três espécies de coccinelídeos, assegurando seu desenvolvimento e reprodução. H. convergens e C. sanguinea apresentaram maior longevidade e capacidade de reprodução e também maior capacidade de predação (3832 e 3633 ninfas de C. atlantica em comparação a 2735 ninfas consumidas por E. connexa durante o ciclo completo, respectivamente para as espécies). Estas espécies de predadores podem contribuir para a redução da população de Cinara no campo.
Resumo:
Purpose: To determine whether the need for retreatment after an initial phase of 3 monthly intravitreal injections of ranibizumab shows an intra-individual regular rhythm and to what degree it varies between different patients. Methods: Prospective study with 42 patients with exudative AMD, treatment naïve. Loading dose of 3 monthly doses of ranibizumab (0,5 mg), followed by a 12 months pro re nata (PRN) regimen according to early exudative signs on HD-OCT Cirrus, Zeiss. The follow-up visits were intensified (week 4, 5, 6, 7, 8, 10, 12, 14, 16, 20, etc after each injection) in order to detect recurrences early, and injection followed within 3 days in cases of subretinal fluid, cysts, or central thickness increase of>50microns. Intervals were calculated between injections for the 12 month follow-up with PRN treatment. Variability was expressed as standard deviation (SD). Results: Visual acuity (VA) improved from a mean ETDRS score of 61.6 (SD 10.8) at baseline to 68.0 (SD 10.2) at month 3 and to 74.7(SD 9.0) at month 12. The 15 patients who have already completed the study showed maintenance of the VA improvement. Central foveal thickness improved from a mean value of 366 microns (baseline) to 253 microns (month 3), well maintained thereafter. Mean number of injections was 8.8 (SD 3.5,range 0-12) per 12 months of follow-up (after 3 doses), with mean individual treatment-recurrence (TR) intervals ranging from 28->365 days (mean 58). Intraindividual variability of TR intervals (SD) was 7.1 days as a mean value (range 1.7¡V22.6). It ranged within 20% of the mean intra-individual interval for 30 (91%) and within 15% for 21 patients (64%). The first interval was within 1 week of the mean intra-individual interval in 64% and within 2 weeks in 89% of patients. Conclusions: The majority of AMD patients showed a relatively stable rhythm for PRN injections of ranibizumab after initial loading phase, associated with excellent functional/anatomical results. The initial interval last loading dose-first recurrence may have a predictive value for further need of treatment, potentially facilitating follow-up and patient care.